136 related articles for article (PubMed ID: 329403)
1. [Prognostic significance of immunologic tests in cancer of the oral cavity].
Szpirglas H; Castet-Sardjveladzé E; Piadé R; Roth-Ghanassia V; Tsamis J
Rev Stomatol Chir Maxillofac; 1977; 78(3):207-18. PubMed ID: 329403
[TBL] [Abstract][Full Text] [Related]
2. The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.
Shillitoe EJ
Proc R Soc Med; 1976 Oct; 69(10):747-9. PubMed ID: 186794
[No Abstract] [Full Text] [Related]
3. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
4. Assays of immunocompetence in the staging and prognosis of cancer.
Robinson JC
Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761
[TBL] [Abstract][Full Text] [Related]
5. [Skin reactions of delayed hypersensitivity in melanoblastoma].
Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
Plesnicar S; Rudolf Z; Lavrencic D
Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses in oral disease: a review.
Lehner T
J Oral Pathol; 1972; 1(1):39-58. PubMed ID: 4626994
[No Abstract] [Full Text] [Related]
8. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
David JR; David RR
Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
[No Abstract] [Full Text] [Related]
9. Cell-mediated immunity in Hurler's syndrome.
Mendes E; Toledo SP
Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
[TBL] [Abstract][Full Text] [Related]
10. [Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer].
Roviaro GC; Varoli F; Sartori F; Calabrò F; Bortolotti F; Tremolada F; Fattovich G; Cecchetto A; Paruzzolo P
Minerva Med; 1980 Jun; 71(25):1757-67. PubMed ID: 6997779
[TBL] [Abstract][Full Text] [Related]
11. [Immunological reactivity indices in malignant tumors of the maxillofacial area].
Malevich OE; Komok AS; Levkovich AN; Mikhaĭlenko AA
Stomatologiia (Mosk); 1981; 60(3):48-51. PubMed ID: 6943792
[No Abstract] [Full Text] [Related]
12. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
Maisel RH; Ogura JH
Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
[No Abstract] [Full Text] [Related]
13. [Cellular immunology tests applied to the diagnosis of immune system dysfunctions].
Bout D
Ann Biol Clin (Paris); 1984; 42(1):87-93. PubMed ID: 6375474
[TBL] [Abstract][Full Text] [Related]
14. [Immune reactions in assessing the disease prognosis in soft tissue sarcomas].
Klimenkov AA; Kadagidze ZG; Gladikov IuV
Vopr Onkol; 1979; 25(1):3-8. PubMed ID: 425395
[TBL] [Abstract][Full Text] [Related]
15. Host immunocompetence in genitourinary cancer: relation to tumor stage and prognosis.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Natl Cancer Inst Monogr; 1978 Dec; (49):105-10. PubMed ID: 311891
[TBL] [Abstract][Full Text] [Related]
16. Immunologic defects in lung cancer patients.
Holmes EC; Golub SH
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
18. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
Das SN; Khanna NN; Khanna S
Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
[TBL] [Abstract][Full Text] [Related]
20. [Control of the course of unspecific cellular immune parameters in patients with squamous epithelial mouth carcinomas].
Bier J; Nicklisch U; Bitter K
Dtsch Zahnarztl Z; 1980 Jan; 35(1):115-7. PubMed ID: 6931714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
